Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Radiological evidence of early cerebral microvascular disease in young children with Fabry disease.
Cabrera-Salazar MA, O'Rourke E, Charria-Ortiz G, Barranger JA. Cabrera-Salazar MA, et al. J Pediatr. 2005 Jul;147(1):102-5. doi: 10.1016/j.jpeds.2005.03.004. J Pediatr. 2005. PMID: 16027705
Gene therapy for the lysosomal storage disorders.
Cabrera-Salazar MA, Novelli E, Barranger JA. Cabrera-Salazar MA, et al. Curr Opin Mol Ther. 2002 Aug;4(4):349-58. Curr Opin Mol Ther. 2002. PMID: 12222873 Review.
Correlation of surrogate markers of Gaucher disease. Implications for long-term follow up of enzyme replacement therapy.
Cabrera-Salazar MA, O'Rourke E, Henderson N, Wessel H, Barranger JA. Cabrera-Salazar MA, et al. Clin Chim Acta. 2004 Jun;344(1-2):101-7. doi: 10.1016/j.cccn.2004.02.018. Clin Chim Acta. 2004. PMID: 15149877
Gaucher disease in Colombia: mutation identification and comparison to other Hispanic populations.
Pomponio RJ, Cabrera-Salazar MA, Echeverri OY, Miller G, Barrera LA. Pomponio RJ, et al. Among authors: cabrera salazar ma. Mol Genet Metab. 2005 Dec;86(4):466-72. doi: 10.1016/j.ymgme.2005.07.026. Epub 2005 Sep 26. Mol Genet Metab. 2005. PMID: 16185907
Intracerebroventricular delivery of glucocerebrosidase reduces substrates and increases lifespan in a mouse model of neuronopathic Gaucher disease.
Cabrera-Salazar MA, Bercury SD, Ziegler RJ, Marshall J, Hodges BL, Chuang WL, Pacheco J, Li L, Cheng SH, Scheule RK. Cabrera-Salazar MA, et al. Exp Neurol. 2010 Oct;225(2):436-44. doi: 10.1016/j.expneurol.2010.07.023. Epub 2010 Jul 29. Exp Neurol. 2010. PMID: 20673762
Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease.
Cabrera-Salazar MA, Deriso M, Bercury SD, Li L, Lydon JT, Weber W, Pande N, Cromwell MA, Copeland D, Leonard J, Cheng SH, Scheule RK. Cabrera-Salazar MA, et al. PLoS One. 2012;7(8):e43310. doi: 10.1371/journal.pone.0043310. Epub 2012 Aug 17. PLoS One. 2012. PMID: 22912851 Free PMC article.
Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile batten disease.
Cabrera-Salazar MA, Roskelley EM, Bu J, Hodges BL, Yew N, Dodge JC, Shihabuddin LS, Sohar I, Sleat DE, Scheule RK, Davidson BL, Cheng SH, Lobel P, Passini MA. Cabrera-Salazar MA, et al. Mol Ther. 2007 Oct;15(10):1782-8. doi: 10.1038/ Epub 2007 Jul 17. Mol Ther. 2007. PMID: 17637720 Free article.
Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff disease.
Ashe KM, Bangari D, Li L, Cabrera-Salazar MA, Bercury SD, Nietupski JB, Cooper CG, Aerts JM, Lee ER, Copeland DP, Cheng SH, Scheule RK, Marshall J. Ashe KM, et al. Among authors: cabrera salazar ma. PLoS One. 2011;6(6):e21758. doi: 10.1371/journal.pone.0021758. Epub 2011 Jun 29. PLoS One. 2011. PMID: 21738789 Free PMC article.
Merits of combination cortical, subcortical, and cerebellar injections for the treatment of Niemann-Pick disease type A.
Bu J, Ashe KM, Bringas J, Marshall J, Dodge JC, Cabrera-Salazar MA, Forsayeth J, Schuchman EH, Bankiewicz KS, Cheng SH, Shihabuddin LS, Passini MA. Bu J, et al. Among authors: cabrera salazar ma. Mol Ther. 2012 Oct;20(10):1893-901. doi: 10.1038/mt.2012.118. Epub 2012 Jul 24. Mol Ther. 2012. PMID: 22828503 Free PMC article.